Koji Sakamoto

9PUBLICATIONS
31CO-AUTHORS
Toxicology (incl. clinical toxicology)Epidemiological methodsExercise physiologyMedical mycologySurface water quality processes and contaminated sediment assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 22, 2025
Risk of Pneumocystis Pneumonia in Patients With Rheumatoid Arthritis and the Role of Prophylactic Salazosulfapyridine.

Ryo Sato, Kenya Terabe, Takahiro Imaizumi

|Nov 08, 2024
Prognostic Awareness and Knowledge of Acute Exacerbation in Patients Dying with Interstitial Lung Disease: A Nationwide Survey.

Takafumi Koyauchi, Tomoyuki Fujisawa, Mitsunori Miyashita

|Apr 03, 2023
Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial.

Kensuke Kataoka, Osamu Nishiyama, Takashi Ogura

|Jun 21, 2022
BMP3b Is a Novel Antifibrotic Molecule Regulated by Meflin in Lung Fibroblasts.

Atsushi Suzuki, Koji Sakamoto, Yoshio Nakahara

|Jun 17, 2021
Size and surface modification of silica nanoparticles affect the severity of lung toxicity by modulating endosomal ROS generation in macrophages.

Masahide Inoue, Koji Sakamoto, Atsushi Suzuki

|May 29, 2021
Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis.

Yoshio Nakahara, Naozumi Hashimoto, Koji Sakamoto

Pageof 2

Frequent Collaborators

3 joint publications

Naozumi Hashimoto

2 joint publications

Keisuke Tomii

1 joint publications

Taylor S Adams

1 joint publications

Sergio Poli